article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

The FDA Law Blog

Palmer — The 2008 Ryan Haight Online Pharmacy Consumer Protection Act placed strict limits on online prescribing or the use of telemedicine encounters to prescribe controlled substances. DEA’s proposed rule when finalized would authorize telemedicine pursuant to the Controlled Substances Act, 21 U.S.C. § By Karla L.

article thumbnail

What is the best medication for anxiety and insomnia?

The Checkup by Singlecare

Ambien and Ambien CR are controlled substances , so they have the potential for substance abuse and dependence. Prescribers will consider past drug use or alcohol use and the potential for abuse and dependence before prescribing a controlled substance. It is a controlled substance.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Alprazolam interactions to avoid

The Checkup by Singlecare

It is also used off-label for other forms of anxiety, like agoraphobia, panic disorders, and acute vertigo episodes. Still, it is a controlled substance and comes with the risk of drug abuse and physical dependence. Food and Drug Administration (FDA) to manage generalized anxiety disorder.

article thumbnail

Zolpidem interactions to avoid

The Checkup by Singlecare

The Food and Drug Administration (FDA) even sent a special communication to call attention to this risk. The Drug Enforcement Administration (DEA) categorizes zolpidem as a controlled substance, meaning that it has significant potential for abuse. For that reason, it is typically best to avoid combining opiates with zolpidem.

article thumbnail

CDC Emphasizes Opioid Guideline is Voluntary and Should Support, Not Supplant, Patient Care

The FDA Law Blog

Clinicians should review FDA-approved labeling and weigh benefits and risks before beginning pharmacologic therapy. Such actions have resulted in “untreated and undertreated pain, serious withdrawal symptoms, worsening pain outcomes, psychological distress, overdose, and suicidal ideation and behavior.”

article thumbnail

OPDP Comes out Swinging With A Warning Letter on Unsubstantiated Efficacy

The FDA Law Blog

Prior to the CytoDyn letter in 2022, OPDP issued a Warning Letter in 2021 to CooperSurgical for a DTC video entitled “Paragard: Family Planning During the Pandemic” which failed to communicate ANY risk information. This seems to suggest that FDA expects this type of outcome claim to be included in labeling.

FDA 52
article thumbnail

Oxycodone (Percocet) alternatives: What can I take instead of oxycodone?

The Checkup by Singlecare

Opioids, like oxycodone, have existed as an effective option for quite some time, but the use of opioids, which are federally controlled substances, carries significant risk and potential for harm if not prescribed and monitored appropriately by your healthcare provider. You should not take more than one opiate at a time.